@ARTICLE{
author={Oh Jiwon|,Drulovic Jelena S|0000-0002-4516-3458,Dufek Michal|,Budincevic Hrvoje|,Habek Mario|,Caunt Maresa|,Cheng Ying-Fang|,Harp Christopher|,Sierzega Malgorzata|,Clayton David|,Ratchford John|,Goodyear Alexandra|,Bar-Or Amit|},
year={2025},
title={Fenebrutinib maintains early and sustained low disease activity in patients with relapsing multiple sclerosis: 2-year results from the FENopta open-label extension},
journal={MULTIPLE SCLEROSIS JOURNAL},
volume={31},
number={3},
pages={109-109},
document_type={Meeting Abstract},
} 

@ARTICLE{
author={Bar-Or Amit|,Oh J|,Dufek Michal|,Budincevic Hrvoje|,Habek Mario|,Caunt Maresa|,Harp C|,Sierzega M|,Clayton David|,Chen Y|,Ratchford JN|,Goodyear Alexandra|,Drulovic Jelena S|0000-0002-4516-3458},
year={2025},
title={Fenebrutinib Maintains Low Disease Activity in Relapsing Multiple Sclerosis: Clinical, Safety and Biomarker Results From the FENopta Open-Label Extension},
journal={MULTIPLE SCLEROSIS JOURNAL},
volume={31},
number={2_SUPPL},
pages={244-244},
document_type={Meeting Abstract},
} 

@ARTICLE{
author={Bar-Or Amit|,Oh Jiwon|,Dufek Michal|,Budincevic Hrvoje|,Habek Mario|,Caunt Maresa|,Thomas Piia|,Sierzega Malgorzata|,Clayton David|,Cheng Ying Fang|,Ratchford John|,Goodyear Alexandra|,Drulovic Jelena S|0000-0002-4516-3458},
year={2024},
title={Fenebrutinib maintains low disease activity in relapsing multiple sclerosis: results from the FENopta trial open-label extension},
journal={MULTIPLE SCLEROSIS JOURNAL},
volume={30},
number={3},
pages={1021-1022},
document_type={Meeting Abstract},
} 

@ARTICLE{
author={Bar-Or Amit|,Dufek Michal|,Budincevic Hrvoje|,Drulovic Jelena S|0000-0002-4516-3458,Habek Mario|,Hua Le|,Weber Martin|,Thomas Piia|,Napieralski Julie|,Clayton David|,Kuruvilla Denison|,Qi Qi|,Xu Yan|,Goodyear Alexandra|,Oh Jiwon|},
year={2023},
title={Cerebrospinal fluid and MRI analyses of fenebrutinib treatment in multiple sclerosis reveal brain penetration and early reduction of new lesion activity: results from the phase II FENopta study},
journal={MULTIPLE SCLEROSIS JOURNAL},
volume={29},
number={},
pages={1049-1050},
document_type={Meeting Abstract},
} 

